ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Invesco Variable Rate Preferred ETF

Invesco Variable Rate Preferred ETF (VRP)

24,31
0,01
(0,04%)
Beim Schlusskurs: 29 Januar 10:00PM
24,31
0,00
( 0,00% )
Nach Börsenschluss: 10:15PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
24,31
Gebot
-
Fragen
-
Volumen
419.079
24,26 Tagesbereich 24,35
23,32 52-Wochen-Bereich 24,67
Marktkapitalisierung
Handelsende
24,30
Handelsbeginn
24,32
Letzte Trade
1035
@
24.31
Letzter Handelszeitpunkt
22:10:00
Finanzvolumen
US$ 10.183.701
VWAP
24,3002
Durchschnittliches Volumen (3 Mio.)
433.860
Ausgegebene Aktien
72.100.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
8,75
Gewinn pro Aktie (EPS)
2,77
Erlöse
95,49M
Nettogewinn
200,05M

Über Invesco Variable Rate Preferred ETF

The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a m... The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a market capitalization-weighted index designed to track the performance of preferred stock, as well as certain types of hybrid securities that are functionally equivalent to preferred stocks, that are issued by U.S.-based or foreign issuers and that pay a floating or variable rate dividend or coupon. It is non-diversified. Mehr anzeigen

Sektor
Mgmt Invt Offices, Open-end
Branche
Mgmt Invt Offices, Open-end
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Invesco Variable Rate Preferred ETF is listed in the Mgmt Invt Offices, Open-end sector of the Amerikanische Börse with ticker VRP. The last closing price for Invesco Variable Rate Pr... was US$24,30. Over the last year, Invesco Variable Rate Pr... shares have traded in a share price range of US$ 23,32 to US$ 24,67.

Invesco Variable Rate Pr... currently has 72.100.000 shares in issue. The market capitalisation of Invesco Variable Rate Pr... is US$1,75 billion. Invesco Variable Rate Pr... has a price to earnings ratio (PE ratio) of 8.75.

VRP Neueste Nachrichten

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verona Pharma plc (Nasdaq: VRNA), please note that all instances of the...

Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

Primary and secondary lung function endpoints met Results support twice-daily dosing LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona...

Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD Completed $200 million private placement Commenced a pilot clinical study in U.S. patients hospitalized with COVID-19 Conference call today at...

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...

LONDON and RALEIGH, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.090.37159372419524.2224.3124.259516624.26824498SP
4-0.01-0.041118421052624.3224.461224.0456629524.234398SP
12-0.12-0.49119934506824.4324.5824.0443386024.33724632SP
260.251.0390689941824.0624.6723.4338123524.2847831SP
520.753.1833616298823.5624.6723.3238357424.01740599SP
156-1.08-4.253643166625.3925.6120.87543387923.16436502SP
260-1.61-6.2114197530925.9226.513.3340379823.74055241SP
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
H9WHwa Ag
3,62 €
(63,06%)
105,19k
0PV2Moovly Media Inc
0,007 €
(55,56%)
650
IFGAAtari SA
0,1695 €
(36,69%)
1,32M
41KQuebec Rare Earth Elements Corp
0,0435 €
(29,85%)
1,02k
76M0Realbotix Corp
0,322 €
(29,84%)
613,19k
5MCLeap Therapeutics Inc
0,635 €
(-70,33%)
12,4k
WWTWater Ways Technologies Inc
0,002 €
(-60,00%)
180k
1UR1Bee Vectoring Technologies International Inc
0,003 €
(-40,00%)
17k
LL3PanGenomic Health Inc
0,1401 €
(-36,23%)
161
OU5AAvalon Advanced Materials Inc
0,0142 €
(-34,86%)
206,52k
D7GNel ASA
0,2018 €
(7,91%)
7,94M
NVDNVIDIA Corp
123,24 €
(9,06%)
2,48M
3MWLivium Ltd
0,0088 €
(-12,00%)
2,17M
3CPXiaomi Corporation
4,88 €
(6,45%)
2,15M
IFGAAtari SA
0,1695 €
(36,69%)
1,32M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock